Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · IEX Real-Time Price · USD
112.19
-1.50 (-1.32%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of $7.02 billion as of July 26, 2024. Its market cap has increased by 95.00% in one year.
Market Cap
7.02B
Enterprise Value
6.79B
1-Year Change
95.00%
Ranking
Category
Stock Price
$112.19
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from $469.40M to $7.02B, an increase of 1,396.59%. That is a compound annual growth rate of 34.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 7.12B | 26.96% |
| Dec 29, 2023 | 5.61B | 113.92% |
| Dec 30, 2022 | 2.62B | -58.41% |
| Dec 31, 2021 | 6.30B | 0.83% |
| Dec 31, 2020 | 6.25B | 58.57% |
| Dec 31, 2019 | 3.94B | 66.35% |
| Dec 31, 2018 | 2.37B | -19.85% |
| Dec 29, 2017 | 2.96B | 285.69% |
| Dec 30, 2016 | 766.50M | 7.38% |
| Dec 31, 2015 | 713.80M | 52.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 7.75B |
| Ascendis Pharma | 7.64B |
| Repligen | 7.40B |
| Penumbra | 7.39B |
| Ionis Pharmaceuticals | 7.32B |
| Summit Therapeutics | 7.15B |
| Halozyme Therapeutics | 7.04B |
| Jazz Pharmaceuticals | 6.86B |